在抗-N-甲基-D-酸盐受体脑炎中低频波动幅度的动态和静态变化
Dongpeng Wu1, Yuanyuan Guo1, Chenglong Li1
1Department of Neurology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, Anhui Province, China.
Brain imaging and behavior
|September 6, 2023
概括
动态大脑活动分析显示,在抗N-甲基-d-酸盐受体 (anti-NMDAR) 脑炎中,局部大脑功能发生变化. 观察到动态ALFF的变异性增加,为这种神经系统疾病提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 神经学 神经学
背景情况:
- 之前的研究集中在对抗N-甲基-d-酸盐受体 (anti-NMDAR) 脑炎的静态大脑活动.
- 在抗NMDAR脑炎的动态局部大脑活动模式之前未被调查.
研究的目的:
- 为了研究反NMDAR脑炎中随时间变化的局部大脑活动变化.
- 为了比较局部大脑活动的动态和静态测量.
主要方法:
- 使用低频波动幅度 (ALFF) 方法.
- 采用滑窗动态分析方法来评估时间变化的大脑活动.
- 将抗NMDAR脑炎患者与健康对照者 (HCs) 进行比较.
主要成果:
- 患者在左下尾环中显示出增加的动态ALFF (dALFF) 变异性.
- 在大脑的广泛区域观察到静态ALFF (sALFF) 的降低,包括额叶和膜.
- 与sALFF相比,dALFF在区分患者和HC方面表现出优异的分类性能.
结论:
- 动态局部大脑活动分析为抗NMDAR脑炎中大脑功能障碍提供了新的视角.
- 结合sALFF和dALFF分析,为理解神经病理机制提供了补充信息.
- 这些发现可能会为未来的自身免疫性脑炎的诊断方法提供信息.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.1K
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
9.9K
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
